Seemal Desai, MD, Responds to Study Suggesting Melanoma is Overdiagnosed in White Patients
Desai emphasized that most dermatologists would rather biopsy a potential melanoma than miss one that could become deadly.
Looking Toward the Future Management of Vitiligo
Looking toward the future management of vitiligo, expert dermatologists close out their discussion on JAK inhibition and other novel therapy.
Novel Therapy in Vitiligo: Topical JAK Inhibitors
Shared insight from dermatologists on novel topical JAK inhibitor therapy being investigated as an option for patients with vitiligo.
Treatment for Vitiligo: Options and Unmet Needs
A brief review of the treatment armamentarium for vitiligo, as well as the prevalent unmet needs in that setting.
Vitiligo: Managing Patient Motivation and Expectations for Treatment
Seemal Desai, MD, FAAD, and William Damsky, MD, PhD, discuss methods for managing a patient’s motivation and expectations when on therapy for vitiligo.
Diagnosing Vitiligo and Improving Care Provider Awareness
Expert perspectives on the diagnosis of vitiligo and considerations for improving provider awareness in dermatologist and community settings.
Vitiligo: Clinical Presentations and Classifications
A comprehensive breakdown of the different classifications of vitiligo and how these may present clinically.
Understanding the Psychosocial Impact of Vitiligo
Shared insight on the psychological and social impact of vitiligo, along with practical advice on how to communicate with and support patients.
An Overview of Vitiligo
Expert dermatologists Seemal Desai, MD, FAAD, and William Damsky, MD, PhD, provide an overview of vitiligo, as an autoimmune disorder, and its prevalence.
